Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$2.1 - $4.83 $18,480 - $42,504
8,800 New
8,800 $38,000
Q3 2023

Nov 07, 2023

SELL
$1.22 - $2.67 $10,248 - $22,428
-8,400 Reduced 55.26%
6,800 $9,000
Q2 2023

Aug 08, 2023

BUY
$2.46 - $3.14 $3,198 - $4,082
1,300 Added 9.35%
15,200 $37,000
Q1 2023

May 12, 2023

SELL
$2.57 - $8.16 $39,400 - $125,100
-15,331 Reduced 52.45%
13,900 $37,000
Q4 2022

Feb 13, 2023

BUY
$5.19 - $13.5 $148,875 - $387,247
28,685 Added 5253.66%
29,231 $158,000
Q3 2022

Nov 07, 2022

SELL
$5.17 - $16.99 $133,080 - $437,339
-25,741 Reduced 97.92%
546 $6,000
Q2 2022

Aug 09, 2022

BUY
$4.04 - $8.51 $106,199 - $223,702
26,287 New
26,287 $129,000
Q1 2022

May 16, 2022

SELL
$7.6 - $11.02 $2,857 - $4,143
-376 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$10.16 - $16.17 $115,204 - $183,351
-11,339 Reduced 96.79%
376 $3,000
Q3 2021

Nov 09, 2021

BUY
$13.16 - $22.47 $151,326 - $258,382
11,499 Added 5323.61%
11,715 $157,000
Q2 2021

Aug 12, 2021

BUY
$19.57 - $26.32 $4,227 - $5,685
216 New
216 $4,000
Q1 2021

May 14, 2021

SELL
$17.58 - $32.59 $12,657 - $23,464
-720 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$10.99 - $20.4 $1,703 - $3,162
-155 Reduced 17.71%
720 $12,000
Q3 2020

Nov 16, 2020

BUY
$11.55 - $23.75 $10,106 - $20,781
875 New
875 $10,000
Q1 2020

May 13, 2020

SELL
$9.07 - $26.32 $53,966 - $156,604
-5,950 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$20.54 - $31.0 $79,530 - $120,032
3,872 Added 186.33%
5,950 $157,000
Q3 2019

Nov 12, 2019

BUY
$22.78 - $40.58 $47,336 - $84,325
2,078 New
2,078 $47,000
Q4 2018

Feb 13, 2019

SELL
$16.51 - $51.33 $19,201 - $59,696
-1,163 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$43.15 - $67.97 $40,863 - $64,367
947 Added 438.43%
1,163 $60,000
Q2 2018

Aug 13, 2018

SELL
$35.06 - $51.17 $58,690 - $85,658
-1,674 Reduced 88.57%
216 $9,000
Q1 2018

May 11, 2018

BUY
$19.05 - $41.76 $36,004 - $78,926
1,890 New
1,890 $70,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.